InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,708.00
(
0.14%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.87
(
0.58%
)
Bitcoin
62,783.74
(
2.17%
)
Post# of 312713
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BioSpecialist

Send PM Follow Ignore
Followers 129
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

BioSpecialist

Re: None

Wednesday, 09/11/2019 3:10:48 PM

Wednesday, September 11, 2019 3:10:48 PM

Post# of 312713
Market cap $35 M /2 Approvals expected next month

Cipher pharma (CPH.TO / CPHRF) (Market cap $35 M) Cash $10 M /Shares Out 26M / Profitable Pharma / 2 Drug Approvals expected next month /undiscovered Low Float stock / =Potential 10 Bagger here guys .GLTA


Presentation
https://filecache.investorroom.com/mr5ircnw_cipher/217/IR%20Deck%20May%202019%20Final.pdf


Cipher Pharma anticipates several key milestones in 2019 that will continue the growth of its Canadian commercial platform, including:

Regulatory approval for plecanatide from Health Canada in Q4 2019 ($200+ Million Market)

Regulatory approval for A-101 from Health Canada in Q4 2019 ($100+ Million Market)

Commercial launch of XYDALBA (dalbavancin) ($60 Million Market)

North American top line results for MOB-015 in Q4 2019
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up